This inventor holds 1 USPTO granted patent and 4 published patent applications. Top assignee: Harvard College. Active years: 2016.
Company Filing History:
Years Active: 2016
Title: Innovations of David Moebius
Introduction
David Moebius is an accomplished inventor based in Cambridge, MA (US). He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on hyperforin analogs. His research focuses on developing methods that can lead to new treatments for various medical conditions.
Latest Patents
David Moebius holds a patent for "Hyperforin analogs, methods of synthesis, and uses thereof." This invention provides a novel 11-step enantioselective approach to the natural product hyperforin. It enables access to a wide variety of hyperforin analogs. The pharmaceutical compositions comprising these inventive hyperforin analogs are envisioned to be useful in treating conditions such as depression, inflammatory skin conditions, diabetes, asthma, chronic obstructive pulmonary disease (COPD), kidney disorders, and ischemic brain damage. He has 1 patent to his name.
Career Highlights
David Moebius is affiliated with Harvard College, where he continues to engage in groundbreaking research. His work has the potential to impact the pharmaceutical industry significantly, particularly in the development of new therapeutic agents.
Collaborations
He has collaborated with notable colleagues, including Brian Andrew Sparling and Matthew D Shair. These partnerships have further enhanced the scope and impact of his research.
Conclusion
David Moebius is a prominent inventor whose work on hyperforin analogs holds promise for advancing medical treatments. His contributions to the field exemplify the importance of innovation in addressing complex health challenges.